ReproCELL Europe Preclinical Drug Trial System
Wide Blue 31 July 2020
ReproCELL Europe Preclinical Drug Trial System
ReproCELL Europe’s PM1 instrument provides real-time information on drug potency by measuring changes in the shape and form of isolated blood vessels during a pre-programmed perfusion schedule. Read the ReproCELL Europe Preclinical Drug Trial System case study
![](https://www.wide-blue.com/wp-content/uploads/2020/07/ReproCELL-Europe-Preclinical-Drug-Trial-System.jpg)